<SEC-DOCUMENT>0001193125-23-233111.txt : 20230912
<SEC-HEADER>0001193125-23-233111.hdr.sgml : 20230912
<ACCEPTANCE-DATETIME>20230912092034
ACCESSION NUMBER:		0001193125-23-233111
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230908
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230912
DATE AS OF CHANGE:		20230912

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			REPLIGEN CORP
		CENTRAL INDEX KEY:			0000730272
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				042729386
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-14656
		FILM NUMBER:		231249124

	BUSINESS ADDRESS:	
		STREET 1:		41 SEYON STREET
		STREET 2:		BUILDING 1, SUITE 100
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		7814499560

	MAIL ADDRESS:	
		STREET 1:		41 SEYON STREET
		STREET 2:		BUILDING 1, SUITE 100
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d554431d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rgen="http://www.repligencorp.com/20230908" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-09-08_to_2023-09-08">REPLIGEN CORP</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-09-08_to_2023-09-08">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-09-08_to_2023-09-08">0000730272</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="rgen-20230908.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-09-08_to_2023-09-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000730272</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-09-08</xbrli:startDate> <xbrli:endDate>2023-09-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-09-08_to_2023-09-08">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt:datemonthdayyearen">September&#160;8, 2023</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">REPLIGEN CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-09-08_to_2023-09-08">000-14656</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-09-08_to_2023-09-08">04-2729386</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-09-08_to_2023-09-08">41 Seyon Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-09-08_to_2023-09-08">Bldg. 1</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2023-09-08_to_2023-09-08">Suite 100</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-09-08_to_2023-09-08">Waltham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-09-08_to_2023-09-08">MA</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-09-08_to_2023-09-08">02453</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-09-08_to_2023-09-08">(781)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-09-08_to_2023-09-08">250-0111</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<span style="font-style:italic">see </span>General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-09-08_to_2023-09-08">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-09-08_to_2023-09-08">RGEN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter). Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-09-08_to_2023-09-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On September&#160;12, 2023, Repligen Corporation (the &#8220;Company&#8221;) announced that Jason K. Garland would be joining the Company as its Chief Financial Officer, effective September&#160;25, 2023 (the &#8220;Effective Date&#8221;), replacing Jon Snodgres, who tendered his intention to retire on September&#160;8, 2023 and who will continue in a full-time advisory role with the Company until October&#160;6, 2023. Effective as of the Effective Date, Mr.&#160;Garland will serve as the Company&#8217;s principal financial officer and principal accounting officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Garland&#8217;s appointment as Chief Financial Officer, the Company and Mr.&#160;Garland entered into an employment agreement, dated September&#160;8, 2023 (the &#8220;Employment Agreement&#8221;), which provides that Mr.&#160;Garland will receive an initial annual base salary of $550,000, and a target annual performance bonus of up to 75% of Mr.&#160;Garland&#8217;s annual base salary. The Employment Agreement also provides that Mr.&#160;Garland will receive a <span style="white-space:nowrap">one-time</span> signing bonus of $100,000, payable within thirty (30)&#160;days after the Effective Date. Mr.&#160;Garland will also be granted an option to purchase shares of the Company&#8217;s common stock and a restricted stock unit award under the Company&#8217;s 2018 Stock Option and Incentive Plan. These awards shall vest in equal annual installments on each of the first, second, third, fourth and fifth anniversaries of the Effective Date, subject to Mr.&#160;Garland&#8217;s continued employment with the Company through the applicable vesting date. The aggregate grant date fair value of the awards will be $1,750,000 and shall be split equally between options and restricted stock units. The Employment Agreement also provides that the Company will grant Mr.&#160;Garland an annual equity award for 2024 worth an aggregate amount of $875,000, 50% of which will be granted in the form of time-based restricted stock units, 25% of which will be granted in the form of options to purchase the Company&#8217;s common stock and 25% of which will be granted in the form of performance-based restricted stock units. Additionally, Mr.&#160;Garland will be eligible to receive certain relocation assistance payments in connection with his relocation to the Boston, Massachusetts area, which amounts are subject to clawback under certain conditions. Mr.&#160;Garland will also be eligible to participate in all customary employee benefit plans or programs generally available to the Company&#8217;s full-time employees and executive officers, including as an &#8220;NEO Participant&#8221; under the Company&#8217;s Severance Plan, which plan is described beginning on page 53 of the Company&#8217;s definitive proxy statement on Schedule 14A for its 2023 annual meeting of stockholders filed with the Securities and Exchange Commission on April&#160;11, 2023. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no arrangements or understandings with any other person pursuant to which Mr.&#160;Garland was appointed as the Company&#8217;s Chief Financial Officer and there are no family relationships between Mr.&#160;Garland and any director or executive officer of the Company. Additionally, there are no transactions between Mr.&#160;Garland and the Company that would be required to be reported under Item 404(a) of Regulation <span style="white-space:nowrap">S-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description of the Employment Agreement is qualified in its entirety by reference to the Employment Agreement, which is filed with this Current Report on Form <span style="white-space:nowrap">8-K</span> as Exhibit 10.1 and is incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information about Mr.&#160;Garland&#8217;s business experience can be found in the press release detailing Mr.&#160;Garland&#8217;s appointment as Chief Financial Officer issued by the Company on September&#160;12, 2023, attached as Exhibit 99.1 hereto, which biographical information contained in paragraphs 2 and 4 thereof is incorporated into this Item 5.02 by reference. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d554431dex101.htm">Employment Agreement, dated as of September&#160;8, 2023, by and between Repligen Corporation and Jason K. Garland. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d554431dex991.htm">Press release issued by Repligen Corporation on September&#160;12, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover page from this Current Report on Form <span style="white-space:nowrap">8-K,</span> formatted in Inline XBRL</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">REPLIGEN CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Dated: September&#160;12, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Tony J. Hunt</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Tony J. Hunt</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d554431dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Employment Agreement (the &#147;<U>Agreement</U>&#148;) is made as of September&nbsp;8, 2023 between Repligen Corporation, a Delaware
corporation (the &#147;<U>Company</U>&#148;), and Jason Garland (the &#147;<U>Executive</U>&#148;) and shall become effective on the first date of the Executive&#146;s employment with the Company, which date is currently anticipated to be
September&nbsp;25, 2023 (such date, or another date if mutually agreed by the parties in writing, the &#147;<U>Effective Date</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company wishes to employ the Executive, and the Executive wishes to be employed, pursuant to the terms described herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Employment</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Position and Duties</U>. The Executive shall serve as the Chief Financial Officer of the Company and shall have such powers and duties
as may from time to time be prescribed by the Company&#146;s Chief Executive Officer (the &#147;<U>CEO</U>&#148;). The Executive shall devote his full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing
sentence, the Executive may serve on one outside board of directors, provided that such board service is approved by the Company&#146;s Board (defined below) and does not conflict with the Executive&#146;s duties to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Compensation and Related Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Base Salary</U>. As of the Effective Date, the Executive&#146;s annual base salary rate shall be $550,000. The Executive&#146;s base
salary shall be reviewed annually by the Compensation Committee (the &#147;<U>Compensation Committee</U>&#148;) of the Board of Directors of the Company (the &#147;<U>Board</U>&#148;). The base salary in effect at any given time is referred to
herein as &#147;<U>Base Salary</U>.&#148; The Base Salary shall be payable in a manner that is consistent with the Company&#146;s usual payroll practices for senior executives. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Annual Bonus</U>. The Executive shall be eligible to receive an annual performance bonus under the Company&#146;s Executive Incentive
Compensation Plan (or such other applicable plan or program adopted by the Company) (the &#147;<U>Bonus Plan</U>&#148;). The Executive&#146;s target annual bonus shall initially be 75%&nbsp;of the Base Salary. The actual bonus will be subject to the
Compensation Committee&#146;s assessment of the Executive&#146;s performance, as well as business conditions at the Company. The bonus also will be subject to approval by and adjustment at the discretion of the Compensation Committee and the terms
of the Bonus Plan. The annual performance bonus, if any, shall be paid between January&nbsp;1 and March&nbsp;15 of the calendar year following the applicable bonus year. The Board expects to review the Executive&#146;s job performance and
responsibilities on at least an annual basis and will discuss with the Executive the criteria which the Compensation Committee will use to assess the Executive&#146;s performance for bonus purposes. The Compensation Committee also may make
adjustments in the targeted amount of the Executive&#146;s annual performance bonus. Any annual bonus for the year in which the Effective Date occurs shall be prorated based on when in the year the Effective Date occurs. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Signing Bonus</U>. The Company shall pay the Executive a signing bonus of $100,000 (the &#147;<U>Signing Bonus</U>&#148;) in a lump sum
within 30 days after the Effective Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Initial and 2024 Equity Awards</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Subject to Compensation Committee approval, the Company shall grant the Executive an option to purchase shares of the
Company&#146;s Common Stock (the &#147;<U>Option Grant</U>&#148;), and a restricted stock unit award (the &#147;<U>RSU Grant</U>&#148; and collectively with the Option Grant, the &#147;<U>Initial Equity Awards</U>&#148;)) under the Company&#146;s
2018 Stock Option and Incentive Plan (as may be amended from time to time, the &#147;<U>Plan</U>&#148;). The aggregate grant date fair value of the Initial Equity Awards shall be $1.75&nbsp;million and shall be split equally (based on grant date
fair value, with the grant date fair value of the Option Grant determined using a Black-Scholes methodology and the Company&#146;s customary assumptions therefor) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
between the Option Grant and the RSU Grant. The Initial Equity Awards shall vest and become exercisable or nonforfeitable (as applicable) in equal installments on each of the first, second,
third, fourth and fifth anniversaries of the Effective Date, subject to the Executive&#146;s continued employment with the Company through the applicable vesting date. The Initial Equity Awards shall be subject to the terms and conditions set forth
in the Plan and in the Stock Option Agreement and Restricted Stock Unit Award Agreements memorializing the terms of the Initial Equity Awards. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Subject to Compensation Committee approval and the Executive&#146;s continued employment as Chief Financial Officer
through the grant date, the Company shall grant the Executive an annual equity award for 2024 in connection with the Executive&#146;s role as Chief Financial Officer, with 50% of the grant in the form of time-based restricted stock units, 25% of the
grant in the form of options to purchase the Company&#146;s Common Stock and 25% of the grant in the form of performance-based restricted stock units (in each case, based on grant date fair value) (collectively, the &#147;<U>2024 Equity
Awards</U>&#148;). The 2024 Equity Awards will be awarded when annual equity awards are granted to other senior executives of the Company. The aggregate grant date fair value of the 2024 Equity Awards shall be $875,000. The 2024 time-based
restricted stock units and 2024 stock option grant shall vest and become exercisable or nonforfeitable (as applicable) in equal installments on each of the first, second and third anniversaries of the grant date, subject to Executive&#146;s
continued employment with the Company through the applicable vesting date. The 2024 performance-based restricted stock units will be earned and vest based upon the achievement of performance criteria to be discussed with the Executive and determined
by the Compensation Committee, subject to the Executive&#146;s continued employment with the Company through the applicable vesting date(s). The 2024 Equity Awards shall be subject to the terms and conditions set forth in the Plan and the stock
option agreement and time- and performance-based restricted stock unit award agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Additional Equity Awards</U>. The
Executive may be eligible to receive additional incentive equity awards under the Company&#146;s executive incentive plans or programs (each such plan or program, an &#147;<U>LTI Plan</U>&#148;). Any actual awards under any LTI Plan (&#147;<U>LTI
Awards</U>&#148;) are discretionary and will be subject to the Board&#146;s assessment of the Executive&#146;s performance, as well as business conditions at the Company. Any LTI Awards will be subject to approval by and adjustment at the discretion
of the Compensation Committee and the terms of any applicable LTI Plan. The Executive will be eligible to participate in the Company&#146;s equity incentive program as may be in effect from time to time in accordance with the terms determined by the
Compensation Committee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Position location, Relocation and Associated Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The location of the position is in Repligen&#146;s Global headquarters in Waltham, Massachusetts, and as such, the
Executive will spend approximately 80% of his working time present at this location. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) To facilitate this transition
to the Boston area, the Company shall pay the Executive an initial lump sum stipend equal to $32,000 (net, after applicable taxes have been withheld), (the &#147;<U>Initial Relocation Stipend</U>&#148;). The Company shall pay the Initial Relocation
Stipend by no later than 30 days following the Effective Date. If Executive does not demonstrate the required presence in Waltham, Massachusetts, over any rolling six (6)&nbsp;month period, if Executive&#146;s employment is terminated by the Company
for Cause, or if Executive resigns without Good Reason, Executive shall repay the entire Initial Relocation Stipend to the Company by no later than 14 days after the Date of Termination.</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) As the Executive intends to relocate the Executive&#146;s primary residence from Texas to the Boston, Massachusetts area
(the &#147;<U>Relocation</U>&#148;), the Company shall pay Executive an additional lump sum relocation stipend equal to $118,000 (net, after applicable taxes have been withheld), if Relocation is completed prior to August&nbsp;1, 2024 (the
&#147;<U>Additional Relocation Stipend</U>&#148;).&nbsp;The date the Relocation occurs is the &#147;<U>Relocation Date</U>.&#148;&nbsp;Subject to the foregoing conditions, the Company shall pay the Additional Relocation Stipend by no later than 30
days following the Relocation Date. The date the Company pays the Additional Relocation Stipend is the &#147;<U>Payment Date</U>.&#148;&nbsp;If Executive&#146;s employment is terminated by the Company for Cause or if Executive resigns without Good
Reason, in either event within the 12 months following the Payment Date (the &#147;<U>Payment Anniversary</U>&#148;), the Executive shall repay a prorated portion of the Additional Relocation Stipend, after taxes (prorated by
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
multiplying the Additional Relocation Stipend amount by a fraction, the numerator of which is the number of days between the Date of Termination (as defined below) and the Payment Anniversary and
the denominator of which is 365) to the Company by no later than 14 days after the Date of Termination.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Business Expenses</U>. The
Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by him during the term of his employment and in performing services hereunder, in accordance with the policies and procedures then in effect and
established by the Company for its senior executive officers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Other Benefits</U>. The Executive shall be eligible to participate
in or receive benefits under the Company&#146;s employee benefit plans in effect from time to time, subject to the terms of such plans, which benefits include, but are not limited to, medical, dental and vision care coverage, short- and long-term
disability and life insurance, and participation in the Company&#146;s 401(k) plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Vacations</U>. The Executive shall be entitled
to paid time off (vacation/personal days) each year in accordance with the Company&#146;s vacation policy as in effect from time to time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <U>Termination</U>. The Executive&#146;s employment hereunder may be terminated without any breach of this Agreement under the following
circumstances: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Death</U>. The Executive&#146;s employment hereunder shall terminate upon his death. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Disability</U>. The Company may terminate the Executive&#146;s employment if he is disabled and unable to perform the essential
functions of the Executive&#146;s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 180 days (which need not be consecutive) in any <FONT STYLE="white-space:nowrap">12-month</FONT>
period. If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive&#146;s then existing position or positions with or without reasonable accommodation,
the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive or the Executive&#146;s guardian has no reasonable objection as to
whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. The Executive shall cooperate with any reasonable request of the
physician in connection with such certification. If such question shall arise and the Executive shall fail to submit such certification, the Company&#146;s determination of such issue shall be binding on the Executive. Nothing in this
Section&nbsp;3(b) shall be construed to waive the Executive&#146;s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. &#167;2601<I>&nbsp;et seq</I>. and the Americans with
Disabilities Act, 42 U.S.C. &#167;12101<I>&nbsp;et seq.</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Termination by Company for Cause</U>. The Company may terminate the
Executive&#146;s employment hereunder for Cause. For purposes of this Agreement, &#147;<U>Cause</U>&#148; is defined in the Severance Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Termination Without Cause</U>. The Company may terminate the Executive&#146;s employment hereunder at any time without Cause. Any
termination by the Company of the Executive&#146;s employment under this Agreement which does not constitute a termination for Cause under Section&nbsp;3(c) and does not result from the death or disability of the Executive under Section&nbsp;3(a) or
(b)&nbsp;shall be deemed a termination without Cause. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination by the Executive</U>. The Executive may terminate his employment
hereunder at any time for any reason, including but not limited to Good Reason. For purposes of this Agreement, &#147;<U>Good Reason</U>&#148; is defined in the Severance Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Notice of Termination</U>. Except for termination as specified in Section&nbsp;3(a), any termination of the Executive&#146;s employment
by the Company or any such termination by the Executive shall be communicated by written Notice of Termination in accordance with Section&nbsp;6(f) of the Severance Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Date of Termination</U>. &#147;<U>Date of Termination</U>&#148; is defined in the Severance Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Compensation Upon Termination</U>. As of the Effective Date, the Executive shall be
eligible as an &#147;<U>NEO Participant</U>&#148; under the Repligen Corporation Amended And Restated Severance And Change In Control Plan (such Plan as in effect from time to time is the &#147;<U>Severance Plan</U>.&#148;) The current version of
the Severance Plan is attached hereto as <U>Exhibit A</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U>Confidential Information, Invention Assignment, Noncompetition,
Nonsolicitation and Cooperation</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) <U>Confidential Information</U>. As used in this Agreement, &#147;<U>Confidential
Information</U>&#148; means information belonging to the Company which is of value to the Company in the course of conducting its business and the disclosure of which could result in a competitive or other disadvantage to the Company. Confidential
Information includes, without limitation, financial information, reports, and forecasts; inventions, improvements and other intellectual property; trade <FONT STYLE="white-space:nowrap">secrets;&nbsp;know-how;&nbsp;designs,</FONT> processes or
formulae; software; market or sales information or plans; customer lists; and business plans, prospects and opportunities (such as possible acquisitions or dispositions of businesses or facilities) which have been discussed or considered by the
management of the Company. Confidential Information includes information developed by the Executive in the course of the Executive&#146;s employment by the Company, as well as other information to which the Executive may have access in connection
with the Executive&#146;s employment. Confidential Information also includes the confidential information of others with which the Company has a business relationship. Notwithstanding the foregoing, Confidential Information does not include
information in the public domain, unless due to breach of the Executive&#146;s duties under Section&nbsp;5(b) (&#147;<U>Confidentiality</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) <U>Confidentiality</U>. The Executive understands and agrees that the Executive&#146;s employment creates a relationship of confidence and
trust between the Executive and the Company with respect to all Confidential Information. At all times, both during the Executive&#146;s employment with the Company and after its termination, the Executive will keep in confidence and trust all such
Confidential Information and will not use or disclose any such Confidential Information without the written consent of the Company, except as may be necessary in the ordinary course of performing the Executive&#146;s duties to the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) <U>Invention Assignment</U>. While employed by the Company and when the Executive ceases to be employed by the Company for any reason, the
Executive promptly and fully shall disclose in writing to the Company and hold in trust for the sole right and benefit of the Company, all ideas, plans, designs, methods, scripts, concepts, recordings, techniques, discoveries, inventions,
developments, improvements, trade secrets, advertising and promotional materials, computer systems, programs, software, source codes, and object codes, specifications, and other proprietary data, records, knowledge, and information that the
Executive solely or jointly knows, creates, conceives, develops, or reduces to practice while employed by the Company, if and to the extent they (a)&nbsp;relate to the business of the Company or any customer of, supplier to or business partner of
the Company or any of the products or services being researched, developed, manufactured or sold by the Company or which may be used with such products or services; or (b)&nbsp;result from tasks assigned to the Executive by the Company or the work
performed by the Executive for the Company; or (c)&nbsp;result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company (collectively, &#147;<U>Intellectual Property</U>&#148;),
whether or not patentable or capable of copyright or trademark registration, and whether or not created, conceived, developed, or reduced to practice during normal working hours, at the request of the Company, or before or after the execution date
of this Agreement. By executing this Agreement, the Executive acknowledges that all work performed by the Executive is on a &#147;work for hire&#148; basis, and Executive assigns and transfers unconditionally all of the Executive&#146;s right,
title, and interest in and to all Intellectual Property to the Company. While employed by the Company and at all times thereafter, the Executive shall do all things, and execute all documents, including applications for patents, copyrights, and
trademarks, and for renewals, extensions, and divisions thereof, that the Company may request to create, enforce, or evidence the Company&#146;s rights to any Intellectual Property. If the Company is unable for any reason whatsoever to obtain the
Executive&#146;s signature or assistance, the Executive irrevocably appoints the Company, and each of its officers, as the Executive&#146;s agent and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact,</FONT></FONT>
with full power of substitution, to sign, execute, and file in the name and behalf of Employee any document required to prosecute or apply for any foreign or United States patent, copyright, trademark, or other proprietary protection, including
renewals, extensions, and divisions, and to do all other lawful acts to further the issuance or prosecution of a patent, copyright, trademark, or other proprietary protection, all with the same legal force and effect as if done or executed by the
Executive. To preclude any possible uncertainty, if there are any intellectual property rights that the Executive has, alone or jointly with others, conceived, developed or reduced to practice prior to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commencement of the Executive&#146;s employment with the Company that the Executive considers to be the Executive&#146;s property or the property of third parties and that the Executive wishes to
have excluded from the scope of this Agreement (&#147;<U>Prior Inventions</U>&#148;), the Executive has provided the Company with a complete list of those Prior Inventions. If disclosure of any such Prior Invention would cause the Executive to
violate any prior confidentiality agreement, the Executive understands that the Executive is not to list such Prior Inventions but is only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the
fact that full disclosure as to such inventions has not been made for that reason. If there are any patents or patent applications in which the Executive is named as an inventor, other than those that have been assigned to the Company
(&#147;<U>Other Patent Rights</U>&#148;), the Executive has also provided a list of those Other Patent Rights to the Company. If no such disclosure is provided to the Company, the Executive represents that there are no Prior Inventions or Other
Patent Rights. If, in the course of the Executive&#146;s employment with the Company, the Executive incorporates a Prior Invention into a Company product, process or machine, research or development program, or other work done for the Company, the
Executive hereby grants to the Company a nonexclusive, royalty-free, fully <FONT STYLE="white-space:nowrap">paid-up,</FONT> irrevocable, worldwide license (with the full right to sublicense directly and indirectly through multiple tiers) to make,
have made, modify, use, sell, offer for sale and import such Prior Invention. Notwithstanding the foregoing, the Executive will not incorporate, or permit to be incorporated, Prior Inventions in any Company Intellectual Property without the
Company&#146;s prior written consent </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) <U>Documents, Records, etc</U>. All documents, records, data, apparatus, equipment and other
physical property, whether or not pertaining to Confidential Information, which are furnished to the Executive by the Company or are produced by the Executive in connection with the Executive&#146;s employment will be and remain the sole property of
the Company. The Executive will return to the Company all such materials and property as and when requested by the Company. In any event, the Executive will return all such materials and property immediately upon termination of the Executive&#146;s
employment for any reason. The Executive will not retain with the Executive any such material or property or any copies thereof after such termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) <U>Noncompetition and Nonsolicitation</U>. The Executive understands that the restrictions set forth in this Section&nbsp;5(e) are
intended to protect the Company&#146;s interest in its Confidential Information and established employee, customer and supplier relationships and goodwill, and agrees that such restrictions are reasonable and appropriate for this purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) During the Executive&#146;s employment with the Company and for 12 months thereafter, regardless of the reason for the
termination (the &#147;<U>Noncompete Restricted Period</U>&#148;), the Executive&nbsp;will not, directly or indirectly, whether as owner, partner, shareholder, consultant, agent, employee, <FONT STYLE="white-space:nowrap">co-venturer</FONT> or
otherwise, engage, participate, assist or invest in any Competing Business (as hereinafter defined). Notwithstanding this foregoing Section&nbsp;5(e)(i), the Executive shall not be subject to the restrictions of this Section&nbsp;5(e)(i) after the
Executive&#146;s employment with the Company ends (nor entitled to the Noncompetition Consideration set forth below) if the Company terminates the Executive&#146;s employment without Noncompete Cause or lays the Executive off. For its part, the
Company agrees to provide the Noncompetition Consideration to the Executive in exchange for the Executive&#146;s post-employment obligations under this Section&nbsp;5(e)(i); <I>provided </I>that the Company may waive its rights under this
Section&nbsp;5(e)(i) and in such event, the Company shall not be obligated to provide the Noncompetition Consideration. The Executive acknowledges that this covenant is necessary because the Company&#146;s legitimate business interests cannot be
adequately protected solely by the other covenants in this Agreement. The Executive further acknowledges and agrees that any payments the Executive receives pursuant to this Section&nbsp;5(e)(i) shall reduce (and shall not be in addition to) any
severance or separation pay that the Executive is otherwise entitled to receive from the Company pursuant to an agreement, plan (including the Severance Plan referred to in this Agreement) or otherwise.&nbsp;Notwithstanding the foregoing, the
Executive may own up to two percent (2%)&nbsp;of the outstanding stock of a publicly held corporation which constitutes or is affiliated with a Competing Business. The Executive acknowledges and agrees that (A)&nbsp;the Executive received this
Agreement at least ten (10)&nbsp;business days before the commencement of the Executive&#146;s employment with the Company; and (B)&nbsp;the Executive has been advised by the Company that the Executive has the right to consult with counsel prior to
signing this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Certain Definitions </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(A) &#147;<U>Competing Business</U>&#148; shall mean any business that develops, sells or markets: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(1) Upstream process intensification tools, downstream chromatography systems, downstream filtration systems, and/or
consumables (including affinity ligands, analytics with a focus on <FONT STYLE="white-space:nowrap">in-line</FONT> analytics and fluid management consumables); and/or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:18%; font-size:10pt; font-family:Times New Roman">(2) Any other products or technologies, including bioprocess products or technologies, developed or acquired, or those that
are in the formative stage of being developed or acquired, by Company during the time period it employed the Executive. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(B) &#147;<U>Noncompete Cause</U>&#148; shall mean a reasonable and good faith basis for the Company to be dissatisfied with
the Executive&#146;s job performance, the Executive&#146;s conduct or the Executive&#146;s behavior. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(C)
&#147;<U>Noncompetition Consideration</U>&#148; shall mean of payments to the Executive for the post-employment portion of the Noncompete Restricted Period (but for not more than twelve (12)&nbsp;months following the end of the Executive&#146;s
employment) at the rate of 50% of the highest annualized base salary paid to the Executive by the Company within the <FONT STYLE="white-space:nowrap">two-year</FONT> period preceding the last day of the Executive&#146;s employment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) During the Executive&#146;s employment with the Company and for 24 months thereafter, regardless of the reason for the
termination, the Executive: (i)&nbsp;will refrain from directly or indirectly employing, attempting to employ, recruiting or otherwise soliciting, inducing or influencing any person to leave employment or engagement with the Company (other than
terminations of employment of subordinate employees undertaken in the course of the Executive&#146;s employment with the Company); and (ii)&nbsp;will refrain from soliciting or encouraging any customer or supplier to terminate or otherwise modify
adversely its business relationship with the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(f) <U>Third-Party Agreements and Rights</U>. The Executive hereby confirms that
the Executive is not bound by the terms of any agreement with any previous employer or other party which restricts in any way the Executive&#146;s use or disclosure of information or the Executive&#146;s engagement in any business. The Executive
represents to the Company that the Executive&#146;s execution of this Agreement, the Executive&#146;s employment with the Company and the performance of the Executive&#146;s proposed duties for the Company will not violate any obligations the
Executive may have to any such previous employer or other party. In the Executive&#146;s work for the Company, the Executive will not disclose or make use of any information in violation of any agreements with or rights of any such previous employer
or other party, and the Executive will not bring to the premises of the Company any copies or other tangible embodiments of <FONT STYLE="white-space:nowrap">non-public</FONT> information belonging to or obtained from any such previous employment or
other party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(g) <U>Litigation and Regulatory Cooperation</U>. During and after the Executive&#146;s employment, the Executive shall
cooperate fully with the Company in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events or occurrences that transpired while the
Executive was employed by the Company. The Executive&#146;s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a
witness on behalf of the Company at mutually convenient times. During and after the Executive&#146;s employment, the Executive also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local
regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse the Executive for any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">reasonable&nbsp;out-of-pocket&nbsp;expenses</FONT></FONT> incurred in connection with the Executive&#146;s performance of obligations pursuant to this subsection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(h) <U>Injunction</U>. The Executive agrees that it would be difficult to measure any damages caused to the Company which might result from
any breach by the Executive of the promises set forth in this Section&nbsp;7, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly, subject to Section&nbsp;6 (&#147;<U>Arbitration of Disputes</U>&#148;)
of this Agreement, the Executive agrees that if the Executive breaches, or proposes to breach, any portion of this Agreement, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate
equitable relief to restrain any such breach without showing or proving any actual damage to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) <U>Protected Disclosures</U>. The Executive understands that nothing contained in this
Agreement limits the Executive&#146;s ability to communicate with any federal, state or local governmental agency or commission, including to provide documents or other information, without notice to the Company. The Executive also understands that
nothing in this Agreement limits the Executive&#146;s ability to share compensation information concerning the Executive or others, except that this does not permit the Executive to disclose compensation information concerning others that the
Executive obtains because the Executive&#146;s job responsibilities require or allow access to such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(j) <U>Defend Trade
Secrets Act of 2016</U>. The Executive understands that pursuant to the federal Defend Trade Secrets Act of 2016, the Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade
secret that (a)&nbsp;is made (i)&nbsp;in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii)&nbsp;solely for the purpose of reporting or investigating a suspected violation of law;
or (b)&nbsp;is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6.
<U>Arbitration of Disputes</U>. Any controversy or claim arising out of or relating to this Agreement or the breach thereof or otherwise arising out of the Executive&#146;s employment or the termination of that employment (including, without
limitation, any claims of unlawful employment discrimination whether based on age or otherwise) shall, to the fullest extent permitted by law, be settled by arbitration in any forum and form agreed upon by the parties or, in the absence of such an
agreement, under the auspices of the American Arbitration Association (&#147;<U>AAA</U>&#148;) in Boston, Massachusetts in accordance with the Employment Dispute Resolution Rules of the AAA, including, but not limited to, the rules and procedures
applicable to the selection of arbitrators. In the event that any person or entity other than the Executive or the Company may be a party with regard to any such controversy or claim, such controversy or claim shall be submitted to arbitration
subject to such other person or entity&#146;s agreement. All <FONT STYLE="white-space:nowrap">AAA-imposed</FONT> costs of said arbitration, including the arbitrator&#146;s fees, if any, shall be borne by the Company. All legal fees incurred by the
parties in connection with such arbitration shall be borne by the party who incurs them, unless applicable statutory authority provides for the award of attorneys&#146; fees to the prevailing party and the arbitrator&#146;s decision and award
provides for the award of such fees. Judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof. This Section shall be specifically enforceable. Notwithstanding the foregoing, this Section shall not
preclude either party from pursuing a court action for the sole purpose of obtaining a temporary restraining order or a preliminary injunction in circumstances in which such relief is appropriate; provided that any other relief shall be pursued
through an arbitration proceeding pursuant to this Section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Consent to Jurisdiction</U>. To the extent that any court action is
permitted consistent with or to enforce Section&nbsp;6 (&#147;<U>Arbitration of Disputes</U>&#148;) of this Agreement, the parties hereby waive any right to a jury with respect to such action and consent to the jurisdiction of the Superior Court of
the Commonwealth of Massachusetts and the United States District Court for the District of Massachusetts. Accordingly, with respect to any such court action, the Executive (a)&nbsp;submits to the personal jurisdiction of such courts;
(b)&nbsp;consents to service of process; and (c)&nbsp;waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <U>Integration</U>. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and
supersedes all prior agreements between the parties concerning such subject matter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <U>Section&nbsp;409A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(a) Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive&#146;s separation from service within the
meaning of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), the Company determines that the Executive is a &#147;specified employee&#148; within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the
Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive&#146;s separation from service would be considered deferred compensation otherwise subject to the 20&nbsp;percent
additional tax imposed pursuant to Section&nbsp;409A(a) of the Code as a result of the application of Section&nbsp;409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the
earlier of (A)&nbsp;six months and one day after the Executive&#146;s separation from service, or (B)&nbsp;the Executive&#146;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a <FONT
STYLE="white-space:nowrap">catch-up</FONT> payment covering amounts that would otherwise have been paid during the <FONT STYLE="white-space:nowrap">six-month</FONT> period but for the application of this provision, and the balance of the
installments shall be payable in accordance with their original schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) All <FONT STYLE="white-space:nowrap">in-kind</FONT>
benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as
administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits
provided or reimbursable expenses incurred in one taxable year shall not affect the <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime
or other aggregate limitation applicable to medical expenses). Such right to reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits is not subject to liquidation or exchange for another benefit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(c) To the extent that any payment or benefit described in this Agreement constitutes
<FONT STYLE="white-space:nowrap">&#147;non-qualified</FONT> deferred compensation&#148; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the Executive&#146;s termination of employment, then such
payments or benefits shall be payable only upon the Executive&#146;s &#147;separation from service.&#148; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in
Treasury <FONT STYLE="white-space:nowrap">Regulation&nbsp;Section&nbsp;1.409A-1(h).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(d) The parties intend that this Agreement
will be administered in accordance with Section&nbsp;409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision shall be read in such a manner so that all
payments hereunder comply with Section&nbsp;409A of the Code. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury
<FONT STYLE="white-space:nowrap">Regulation&nbsp;Section&nbsp;1.409A-2(b)(2).</FONT> The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section&nbsp;409A of the
Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(e) The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of
this Agreement are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do not satisfy an exemption from, or the conditions of, such Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <U>Withholding</U>. All payments made by the Company to the Executive under this Agreement shall be net of any tax or other amounts
required to be withheld by the Company under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <U>Indemnification and D&nbsp;&amp; O Insurance</U>. The Executive shall
be entitled to benefit from the Company&#146;s officer indemnification agreements and insurance coverage to the same extent as other senior executive officers of the Company (including the right to such coverage or benefit following the
Executive&#146;s employment to the extent liability continues to exist). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <U>Successor to the Executive</U>. This Agreement shall
inure to the benefit of and be enforceable by the Executive&#146;s personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of the Executive&#146;s death after his termination of employment but
prior to the completion by the Company of all payments due him under this Agreement, the Company shall continue such payments to the Executive&#146;s beneficiary designated in writing to the Company prior to his death (or to his estate, if the
Executive fails to make such designation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <U>Enforceability</U>. If any portion or provision of this Agreement (including, without
limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or
provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by
law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14. <U>Survival</U>. The provisions of this Agreement shall survive the termination of this
Agreement and/or the termination of the Executive&#146;s employment to the extent necessary to effectuate the terms contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15.
<U>Waiver</U>. The Company and the Executive acknowledge and agree that the Company may unilaterally waive the Executive&#146;s post-employment noncompetition obligations under Section&nbsp;5(e)(i), and in the event of such a waiver, the Company is
not required to pay the Executive any post-employment Noncompetition Consideration under this Agreement. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party to require
the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16. <U>Notices</U>. Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing
and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last address the Executive has filed in writing with the
Company or, in the case of the Company, at its main offices, attention of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17. <U>Amendment</U>. This Agreement may be amended
or modified only by a written instrument signed by the Executive and by the Company&#146;s CEO or Chairperson of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18.
<U>Governing Law</U>. This is a Massachusetts contract and shall be construed under and be governed in all respects by the laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws principles of such Commonwealth. With
respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals for the First Circuit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19. <U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be
taken to be an original; but such counterparts shall together constitute one and the same document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">20. <U>Assignment</U>. Neither the
Company nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent of the other party. Notwithstanding the foregoing, the Company may assign its rights
under this Agreement without any such further consent of the Executive to any successor in interest to the Company including in the event that the Company shall effect a reorganization, consolidate with or merge into any other corporation, limited
liability company, partnership, organization or other entity, or transfer all or substantially all of its properties or assets to any other corporation, limited liability company, partnership, organization or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">21. <U>Successor to Company</U>. The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or
otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this Agreement to the same extent that the Company would be required to perform it if no succession had taken place. Failure of
the Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a material breach of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">22. <U>Gender Neutral</U>. Wherever used herein, a pronoun in the masculine gender shall be considered as including the feminine gender unless
the context clearly indicates otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first
above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>REPLIGEN CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Anthony Hunt</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: Anthony Hunt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its: Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>EXECUTIVE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jason Garland</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jason Garland</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit A: Current Severance Plan </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPLIGEN CORPORATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND
RESTATED </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SEVERANCE AND CHANGE IN CONTROL PLAN </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Repligen Corporation (the &#147;Company&#148;) considers it essential to the best interests of its stockholders to foster the continuous
employment of key management personnel. The Board of Directors of the Company (the &#147;Board&#148;) recognizes, however, that, as is the case with many publicly held corporations, the possibility of an involuntary termination of employment, either
before or after a Change in Control (as defined in Section&nbsp;1 hereof), exists and that such possibility, and the uncertainty and questions that it may raise among management, may result in the departure or distraction of management personnel to
the detriment of the Company and its stockholders. Therefore, the Board has determined that the Repligen Corporation Amended and Restated Severance and Change in Control Plan (the &#147;Plan&#148;) should be adopted to reinforce and encourage the
continued attention and dedication of the Company&#146;s Eligible Participants (as defined in Section&nbsp;1 hereof) to their assigned duties without distraction. Nothing in this Plan shall be construed as creating an express or implied contract of
employment and nothing shall alter the &#147;at will&#148; nature of the Eligible Participants&#146; employment with the Company. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Definitions.</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<I>Accelerated Vesting Date</I>&#148; means the later of the (i)&nbsp;Eligible Participant&#146;s Date of Termination, or
(ii)&nbsp;effective date of the Eligible Participant&#146;s Separation Agreement and Release. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<I>Accrued Benefits</I>&#148;
means any earned but unpaid salary, unpaid expense reimbursements and accrued but unused vacation or paid time off, if applicable, which amounts shall be paid to the Eligible Participant within the time required by law but in no event more than 30
days after the Date of Termination. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<I>Administrator</I>&#148; means the Board or the Compensation Committee of the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<I>Base Salary</I>&#148; means the higher of the Eligible Participant&#146;s annual base salary in effect immediately prior to
(i)&nbsp;the Eligible Participant&#146;s Date of Termination or (ii)&nbsp;the Change in Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<I>Cause</I>&#148; means:
(i)&nbsp;conduct constituting a material act of misconduct in connection with the performance of the Eligible Participant&#146;s duties to the Company, including, without limitation, misappropriation of funds or property of the Company or any of its
subsidiaries or affiliates other than the occasional, customary and<I>&nbsp;de minimis</I><I></I>&nbsp;use of Company property for personal purposes; (ii)&nbsp;the commission of any felony or a misdemeanor involving moral turpitude, deceit,
dishonesty or <FONT STYLE="white-space:nowrap">fraud;&nbsp;(iii)&nbsp;non-performance&nbsp;of</FONT> the Eligible Participant&#146;s duties to the Company (other than by reason of the Eligible Participant&#146;s physical or mental illness,
incapacity or disability) or repeated violations of the Eligible Participant&#146;s material responsibilities and material duties as determined in good faith by the Company and which has continued for more than 30 days following written notice,
which notice shall specify in reasonable detail the performance problems and the actions required to cure such performance problems; (iv)&nbsp;a breach by the Eligible Participant of any of the material provisions contained in any written agreement
by and between the Eligible Participant and the Company that, if curable, is not cured within 30 days after the Company notifies the Eligible Participant in writing that it believes the Eligible Participant has breached
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such material provision, which notice shall specify in reasonable detail such breach and the actions required to cure such breach; (v)&nbsp;the Eligible Participant&#146;s material violation of
any of the Company&#146;s written employment policies that has continued for more than 30 days following written notice thereof, which notice shall specify in reasonable detail such violation and the actions required to cure such violation; or
(vi)&nbsp;the Eligible Participant&#146;s failure to cooperate with a bona fide internal investigation or an investigation by regulatory or law enforcement authorities, after being instructed by the Company to cooperate, or the Eligible
Participant&#146;s willful destruction or failure to preserve documents or other materials known to be relevant to such investigation or inducement of others to fail to cooperate or to produce documents or other materials in connection with such
investigation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<I>Change in Control</I>&#148; means a Sale Event, as defined in the Company&#146;s 2018 Stock Option and
Incentive Plan, as amended from time to time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) &#147;<I>Change in Control Period</I>&#148; means
<FONT STYLE="white-space:nowrap">the&nbsp;two-year&nbsp;period</FONT> immediately following a Change in Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)
&#147;<I>Code</I>&#148; means the Internal Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) &#147;<I>Date of Termination</I>&#148; means the date
that an Eligible Participant&#146;s employment with the Company (or any successor) ends. Notwithstanding the foregoing, an Eligible Participant&#146;s employment shall not be deemed to have been terminated solely as a result of the Eligible
Participant becoming an employee of any subsidiary of the Company or any direct or indirect successor to the business or assets of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<I>Eligible Participants</I>&#148; means those executives or employees designated as such by the Administrator in its sole
discretion, who are listed in <U>Schedule C</U>, attached hereto, as such schedule is amended by the Administrator from time to time, and who meet the eligibility requirements set forth in Section&nbsp;3 of this Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) &#147;<I>Equity Awards</I>&#148; means all Stock Options, Time-Based Awards and Performance-Based Awards held by the Eligible Participants.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) &#147;<I>Executive Team Participant</I>&#148; means each Eligible Participant who is not an NEO Participant who meets the eligibility
requirements set forth in Section&nbsp;3 of this Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) &#147;<I>Good Reason</I>&#148; means that the Eligible Participant has complied
with the &#147;Good Reason Process&#148; following the occurrence of any of the following events: (i)&nbsp;a material diminution in the Eligible Participant&#146;s base salary, except
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">for&nbsp;across-the-board&nbsp;salary</FONT></FONT> reductions based on the Company&#146;s financial performance similarly affecting all or substantially all senior management
employees of the Company; (ii)&nbsp;a material diminution in the Eligible Participant&#146;s authority, duties, or responsibilities; (iii)&nbsp;a material change in the geographic location of the Company office where the Eligible Participant is
principally employed and required to perform services for the Company, except for required travel on the Company&#146;s business to an extent substantially consistent with his or her present business travel obligations or the business travel
obligations of any subsequent position at the Company occupied by the Eligible Participant; and (iv)&nbsp;any other action or inaction that constitutes a material breach by the Company of a written employment agreement between the Company and the
Eligible Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) &#147;<I>Good Reason Process</I>&#148; means that (i)&nbsp;the Eligible Participant
reasonably determines in good faith that a &#147;Good Reason&#148; condition has occurred; (ii)&nbsp;the Eligible Participant notifies the Company in writing of the first occurrence of the Good Reason condition within 90 days of the first occurrence
of such condition; (iii)&nbsp;the Eligible Participant cooperates in good faith with the Company&#146;s efforts, for a period not less than 30 days following such notice (the &#147;Cure Period&#148;), to remedy the condition; and
(iv)&nbsp;notwithstanding such efforts, the Good Reason condition continues to exist. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred. If the Company does not cure the Good
Reason condition during the Cure Period, then termination for Good Reason shall be deemed to have occurred on the 31<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>&nbsp;day after the Company received notice from the Eligible Participant
pursuant to clause (ii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) &#147;<I>NEO Participant</I>&#148; means each Eligible Participant set forth on&nbsp;<U>Schedule
D</U>&nbsp;attached hereto, as such schedule may be amended by the Administrator from time to time, and who meets the eligibility requirements set forth in Section&nbsp;3 of this Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) &#147;<I>Participation Agreement</I>&#148; means an agreement between an Eligible Participant and the Company that acknowledges the
Eligible Participant&#146;s participation in this Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) &#147;<I>Performance-Based Awards</I>&#148; means all then-outstanding stock
options and other stock-based awards of the Company that are subject to performance-based vesting and for which achievement of the performance metrics has not been determined as of the Date of Termination. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) &#147;<I>Stock Options</I>&#148; means all then-outstanding options to purchase common stock of the Company that are subject to time-based
vesting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) &#147;<I>Target Bonus</I>&#148; means the Eligible Participant&#146;s target annual incentive compensation for the
then-current year. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) &#147;<I>Time-Based Awards</I>&#148; means all then-outstanding stock-based awards (including restricted stock
awards and restricted stock unit awards) of the Company, other than Stock Options, that are subject solely to time-based vesting. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Administration of the Plan</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;<U>Administrator</U>. The Plan shall be administered by the Administrator. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;<U>Powers of Administrator</U>. The Administrator shall have all powers necessary to enable it properly to carry out its duties with
respect to the complete control of the administration of the Plan. Not in limitation, but in amplification of the foregoing, the Administrator shall have the power and authority in its discretion to: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) construe the Plan to determine all questions that shall arise as to
interpretations of the Plan&#146;s provisions; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) determine which individuals are and are not Eligible Participants,
determine the benefits to which any Eligible Participants may be entitled, the eligibility requirements for participation in the Plan and all other matters pertaining to the Plan; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) adopt amendments to the Plan which are deemed necessary or desirable to comply with all applicable laws and regulations,
including but not limited to Section&nbsp;409A of the Code and the guidance thereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) make all determinations it
deems advisable for the administration of the Plan, including the authority and ability to delegate administrative functions to a third party; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) decide all disputes arising in connection with the Plan; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) otherwise supervise the administration of the Plan. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All decisions and interpretations of the Administrator shall be conclusive and binding on all persons, including the Company and Eligible
Participants. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Eligibility</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">All Eligible Participants who have executed and submitted to the Company a Participation Agreement, and satisfied such other requirements as
may be determined by the Administrator, are eligible to participate in the Plan. Notwithstanding the foregoing, the Administrator may determine at any time that an Eligible Participant should no longer be designated as such as a result of a material
change in such Eligible Participant&#146;s role, and such individual shall cease to be eligible to participate in the Plan upon the Administrator taking action by resolution to update&nbsp;<U>Schedule C</U>&nbsp;hereto. In addition, the
Administrator may determine at any time that an NEO Participant should be instead designated as an Executive Team Participant as a result of a material change in such NEO Participant&#146;s role, and such individual shall be Executive Team
Participant and shall no longer be an NEO Participant upon the Administrator taking action by resolution to update&nbsp;<U>Schedule D</U>&nbsp;hereto. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Termination Not in Connection with a Change in Control</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the employment of an Eligible Participant is terminated by the Company without Cause, then, in addition to the Accrued Benefits, subject to
the execution of a separation agreement and release in a form and manner satisfactory to and provided by the Company that contains, among other provisions, a general release of claims in favor of the Company and related persons and entities,
confidentiality, return of property <FONT STYLE="white-space:nowrap">and&nbsp;non-disparagement&nbsp;provisions</FONT><B>,</B><B></B>&nbsp;employee and <FONT STYLE="white-space:nowrap">customer&nbsp;non-solicitation&nbsp;provisions</FONT> that apply
for two years following the Date of Termination, <FONT STYLE="white-space:nowrap">a&nbsp;non-competition&nbsp;provision</FONT> that applies for one year following the Date of Termination, and a seven day revocation period (the &#147;Separation
Agreement and Release&#148;), by the Eligible Participant and the Separation Agreement and Release becoming irrevocable, all within the time frame set forth in the Separation Agreement and Release but in no event to exceed 60 days from the Date of
Termination, such Eligible Participant shall be entitled to receive the severance payments and benefits provided in&nbsp;<U>Schedule A</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>Termination in Connection with a Change in Control</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If the employment of an Eligible Participant is terminated by the Company (or its successor) without Cause or such Eligible Participant resigns
for Good Reason, in either case during the Change in Control Period, then, in addition to the Accrued Benefits, subject to the execution of the Separation Agreement and Release by the Eligible Participant and the Separation Agreement and Release
becoming irrevocable, all within the time frame set forth in the Separation Agreement and Release but in no event to exceed 60 days from the Date of Termination, such Eligible Participant shall be entitled to receive the severance payments and
benefits provided in&nbsp;<U>Schedule B</U>. The provisions of this Section&nbsp;5 shall apply in lieu of, and expressly supersede, the provisions of Section&nbsp;4 regarding severance payments and benefits upon a termination of employment, if such
termination of employment occurs within the Change in Control Period. This Section&nbsp;5 shall terminate and be of no further force or effect beginning immediately following the end of the Change in Control Period. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><U>General Terms and Conditions.</U> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;<U>Payments</U>. Subject to the effectiveness of the Separation Agreement and Release, the amounts payable pursuant to this Plan shall
be paid as set forth on <U>Schedule A</U>&nbsp;or&nbsp;<U>Schedule B</U>, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;<U>Tax Withholding</U>. All payments
made by the Company under this Plan shall be subject to any tax or other amounts required to be withheld by the Company under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;<U>Section&nbsp;409A</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Anything in this Plan to the contrary notwithstanding, if at the time of the Eligible Participant&#146;s &#147;separation
from service&#148; within the meaning of Section&nbsp;409A of the Code, the Company determines that the Eligible Participant is a &#147;specified employee&#148; within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, then to the extent any
payment or benefit that the Eligible Participant becomes entitled to under this Plan would be considered deferred compensation subject to the 20&nbsp;percent additional tax imposed pursuant to Section&nbsp;409A(a) of the Code as a result of the
application of Section&nbsp;409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (i)&nbsp;six months and one day after the Eligible Participant&#146;s separation
from service, or (ii)&nbsp;the Eligible Participant&#146;s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include <FONT STYLE="white-space:nowrap">a&nbsp;catch-up&nbsp;payment</FONT>
covering amounts that would otherwise have been paid during <FONT STYLE="white-space:nowrap">the&nbsp;six-month&nbsp;period</FONT> but for the application of this provision, and the balance of the installments shall be payable in accordance with
their original schedule. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The parties intend that this Plan will be administered in accordance
with Section&nbsp;409A of the Code and that all amounts payable hereunder shall be exempt from the requirements of such section to the greatest extent possible. To the extent that any provision of this Plan is not exempt from Section&nbsp;409A of
the Code and ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision shall be read in such a manner to comply with Section&nbsp;409A of the Code. Each payment pursuant to this Plan is intended to constitute a separate
payment for purposes of Treasury <FONT STYLE="white-space:nowrap">Regulation&nbsp;Section&nbsp;1.409A-2(b)(2).&nbsp;The</FONT> parties agree that this Plan may be amended, as reasonably requested by either party, and as may be necessary to fully
comply with Section&nbsp;409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) To the extent that any payment or benefit described in this Plan
<FONT STYLE="white-space:nowrap">constitutes&nbsp;&#147;non-qualified&nbsp;deferred</FONT> compensation&#148; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the Eligible Participant&#146;s
termination of employment, then such payments or benefits shall be payable only upon the Eligible Participant&#146;s &#147;separation from service.&#148; The determination of whether and when a separation from service has occurred shall be made in
accordance with the presumptions set forth in Treasury <FONT STYLE="white-space:nowrap">Regulation&nbsp;Section&nbsp;1.409A-1(h).</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <FONT STYLE="white-space:nowrap">All&nbsp;in-kind&nbsp;benefits</FONT> provided and expenses eligible for reimbursement
under this Plan shall be provided by the Company or incurred by the Eligible Participant during the time periods set forth in this Plan. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any
reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount <FONT STYLE="white-space:nowrap">of&nbsp;in-kind&nbsp;benefits</FONT> provided or reimbursable expenses incurred in
one taxable year shall not affect <FONT STYLE="white-space:nowrap">the&nbsp;in-kind&nbsp;benefits</FONT> to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation
applicable to medical expenses). Such right to reimbursement <FONT STYLE="white-space:nowrap">or&nbsp;in-kind&nbsp;benefits</FONT> is not subject to liquidation or exchange for another benefit. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) The Company makes no representation or warranty and shall have no liability to any Eligible Participant or any other person
if any provisions of this Plan are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do not satisfy an exemption from, or the conditions of, such Section. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;<U>Additional Limitation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Anything in this Plan to the contrary notwithstanding, in the event that the amount of any compensation, payment or
distribution by the Company to or for the benefit of any Eligible Participant, whether paid or payable or distributed or distributable pursuant to the terms of this Plan or otherwise, calculated in a manner consistent with Section&nbsp;280G of the
Code, and the applicable regulations thereunder (the &#147;Aggregate Payments&#148;), would be subject to the excise tax imposed by Section&nbsp;4999 of the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of
all of the Aggregate Payments shall be $1.00 less than the amount at which the Eligible Participant becomes subject to the excise tax imposed by Section&nbsp;4999 of the Code; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
provided that such reduction shall only occur if it would result in the Eligible Participant receiving a higher After Tax Amount (as defined below) than the Eligible Participant would receive if
the Aggregate Payments were not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following order, in each case, in reverse chronological order beginning with the Aggregate Payments that are to be paid the
furthest in time from consummation of the transaction that is subject to Section&nbsp;280G of the Code: (1)&nbsp;cash payments not subject to Section&nbsp;409A of the Code; (2)&nbsp;cash payments subject to Section&nbsp;409A of the Code;
(3)&nbsp;equity-based payments and acceleration; <FONT STYLE="white-space:nowrap">and&nbsp;(4)&nbsp;non-cash&nbsp;forms</FONT> of benefits; provided that, in the case of all the foregoing Aggregate Payments, all amounts or payments that are not
subject to calculation under Treas. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Reg.&nbsp;&#167;1.280G-1,&nbsp;Q&amp;A-24(b)&nbsp;or</FONT></FONT> (c)&nbsp;shall be reduced before any amounts that are subject to calculation
under Treas. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Reg.&nbsp;&#167;1.280G-1,&nbsp;Q&amp;A-24(b)&nbsp;or</FONT></FONT> (c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) For purposes of this Section&nbsp;6(d), the &#147;After Tax Amount&#148; means the amount of the Aggregate Payments less
all federal, state, and local income, excise and employment taxes imposed on the Eligible Participant as a result of the Eligible Participant&#146;s receipt of the Aggregate Payments. For purposes of determining the After Tax Amount, the Eligible
Participant shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest
marginal rates of individual taxation in each applicable state and locality, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section&nbsp;6(d)(i)
shall be made by a nationally recognized accounting firm selected by the Company (the &#147;Accounting Firm&#148;), which shall provide detailed supporting calculations both to the Company and the Eligible Participant within 15 business days of the
Date of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or the Eligible Participant. Any determination by the Accounting Firm shall be binding upon the Company and the Eligible Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Unfunded Plan</U>. This Plan shall be unfunded and shall not create (or be construed to create) a trust or separate fund. Likewise, the
Plan shall not establish any fiduciary relationship between the Company or any of its subsidiaries or affiliates and any Eligible Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;<U>Notice and Communication of Date of Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;<U>Notice of Termination</U>. A termination of the Eligible Participant&#146;s employment shall be communicated by a
Notice of Termination from the Company to the Eligible Participant or vice versa in accordance with this Section&nbsp;6(f). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;<U>Delivery of Notice</U>. Any notices, requests, demands, and other communications provided for by this Plan shall
be sufficient if in writing and delivered in person or sent by registered or certified mail, postage prepaid, to an Eligible Participant at the last address the Eligible Participant has filed in writing with the Company, or to the Company at the
following physical or email address: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Repligen Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Chief Human Resources Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">41 Seyon Street, Building 1 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Waltham, Massachusetts 02453 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;<U>No Mitigation</U>. Eligible Participants are not required to seek other employment or to attempt in any way to reduce any amounts
payable to an Eligible Participant under this Plan. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;<U>Benefits and Burdens</U>. This Plan shall inure to the benefit of and be
binding upon the Company and the Eligible Participants, their respective successors, executors, administrators, heirs and permitted assigns. In the event of an Eligible Participant&#146;s death after a termination of employment but prior to the
completion of all payments due to him or her under this Plan, the Company (or its successor) shall continue such payments to the Eligible Participant&#146;s beneficiary designated in writing to the Company prior to his or her death (or to his or her
estate, if the Eligible Participant fails to make such designation). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;<U>Enforceability</U>. If any portion or provision of this
Plan shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Plan, or the application of such portion or provision in circumstances other than those as to which it is so declared
illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Plan shall be valid and enforceable to the fullest extent permitted by law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;<U>Waiver</U>. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The
failure of any party to require the performance of any term or obligation of this Plan, or the waiver by any party of any breach of this Plan, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any
subsequent breach. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;<U><FONT STYLE="white-space:nowrap">Non-Duplication&nbsp;of</FONT> Benefits and Effect on Other Plans</U>.
Notwithstanding any other provision in the Plan to the contrary, the benefits provided hereunder shall be in lieu of any other severance payments and/or benefits provided by the Company, including, without limitation, any such payments and/or
benefits pursuant to an employment agreement or offer letter between the Company and the Eligible Participant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;<U>No Contract of
Employment</U>. Nothing in this Plan shall be construed as giving any Eligible Participant any right to be retained in the employ of the Company or shall affect the terms and conditions of an Eligible Participant&#146;s employment with the Company.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;<U>Amendment or Termination of Plan</U>. The Company may amend or terminate this Plan at any time or from time to time, but no
such action shall adversely affect the rights of any Eligible Participant without the Eligible Participant&#146;s written consent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;<U>Obligations of Successors</U>. In addition to any obligations imposed by law
upon any successor to the Company, any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company shall expressly assume and agree to perform this Plan
in the same manner and to the same extent that the Company would be required to perform if no such succession had taken place. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;<U>Governing Law</U>. The Plan shall be construed in accordance with and governed by the laws of the Commonwealth of Massachusetts,
without regard to principles of conflict of laws of such state. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;<U>Effective Date</U>. This Plan is effective as of May&nbsp;26,
2022 (the &#147;Effective Date&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Severance Benefits </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a
termination of an Eligible Participant&#146;s employment under the circumstances set forth in Section&nbsp;4 of the Plan, and subject to the terms and conditions of the Plan, the Eligible Participant shall be entitled to the following severance
payments and benefits: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An amount equal to (i)&nbsp;in the case of the NEO Participants, one times the Eligible Participant&#146;s Base
Salary and (ii)&nbsp;in the case of the Executive Team Participants, 0.5 times the Eligible Participant&#146;s Base Salary; provided, however that, in each case, such amount shall be reduced by an amount equal to the dollar value of the portion of
the monthly premiums paid by active employees for coverage under the Company&#146;s group health care programs multiplied by (x) 12 in the case of NEO Participants and (y)&nbsp;six in the case of Executive Team Participants (such amount, the
&#147;Severance Amount&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Eligible Participant is enrolled in the Company&#146;s group health care programs immediately prior to
the Date of Termination and properly elects to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;COBRA&#148;), COBRA premiums for the Eligible Participant and the Eligible Participant&#146;s
eligible dependents for the Severance Period (as defined below); provided, however, if the Company determines that it cannot pay such amounts without potentially violating applicable law (including, without limitation, Section&nbsp;2716 of the
Public Health Service Act), the Company will in lieu thereof provide to the Eligible Participant a taxable monthly payment in an amount equal to the COBRA premiums for the Eligible Participant and the Eligible Participant&#146;s eligible dependents
for the Severance Period. For the avoidance of doubt, the taxable payments described above may be used for any purpose, including, but not limited to, continuation coverage under COBRA; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For each NEO Participant, except as otherwise expressly provided in any applicable Equity Award agreement,
effective as of the Accelerated Vesting Date, (A) 50% of the unvested portion of all Stock Options held by the NEO Participant shall immediately accelerate and become fully exercisable or nonforfeitable,
<FONT STYLE="white-space:nowrap">(B)&nbsp;a&nbsp;pro-rata&nbsp;portion</FONT> of Time-Based Awards shall become exercisable or nonforfeitable and <FONT STYLE="white-space:nowrap">(C)&nbsp;a&nbsp;pro-rata&nbsp;portion</FONT> of all Performance-Based
Awards held by the NEO Participant shall become exercisable or nonforfeitable at the end of the performance period based on actual performance through the end of the performance period (and such awards shall remain outstanding through the end of the
applicable performance <FONT STYLE="white-space:nowrap">period).&nbsp;Pro-ration&nbsp;for</FONT> purposes of this Section&nbsp;3 of&nbsp;<U>Schedule A</U>&nbsp;shall be determined based on the number of full months elapsed in the vesting period or
performance period, as applicable, through the Date of Termination relative to the total number of full months in the vesting period or performance period, as applicable. Notwithstanding anything to the contrary in the applicable plans and/or award
agreements governing the Stock Options and Time-Based Awards, any termination or forfeiture of unvested shares underlying such awards that could vest pursuant to this Section&nbsp;3 of&nbsp;<U>Schedule A</U>&nbsp;and otherwise would have occurred on
or prior to the Accelerated Vesting Date will be delayed until the Accelerated Vesting Date and will occur only to the extent the Stock Options and Time-Based Awards do not vest pursuant to this Section&nbsp;3 of&nbsp;<U>Schedule A</U>.
Notwithstanding the foregoing, no additional vesting of Stock Options and Time-Based Awards shall occur during the period between the Eligible Participant&#146;s Date of Termination and the Accelerated Vesting Date. For the avoidance of doubt,
Executive Team Participants shall not be entitled to the acceleration of vesting set forth in this Section&nbsp;3 of&nbsp;<U>Schedule A</U>. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The amounts payable under Section&nbsp;1 of this&nbsp;<U>Schedule A</U>&nbsp;shall be paid
out in substantially equal installments in accordance with the Company&#146;s payroll practice over (i) 12 months in the case of the NEO Participants and (ii)&nbsp;six months in the case of the Executive Team Participants (such period, the
&#147;Severance Period&#148;), commencing on the first payroll date following the effective date of the Separation Agreement and Release and, in any case, within 60 days after the Date of Termination; provided, however, that if <FONT
STYLE="white-space:nowrap">the&nbsp;60-day&nbsp;period</FONT> begins in one calendar year and ends in a second calendar year, the Severance Amount to the extent it qualifies <FONT STYLE="white-space:nowrap">as&nbsp;&#147;non-&nbsp;qualified</FONT>
deferred compensation&#148; within the meaning of Section&nbsp;409A of the Code, shall begin to be paid no earlier than the first Company payroll date in the second calendar year and, in any case, by the last day of
<FONT STYLE="white-space:nowrap">such&nbsp;60-day&nbsp;period;</FONT> provided, further, that the initial payment shall include <FONT STYLE="white-space:nowrap">a&nbsp;catch-up&nbsp;payment</FONT> to cover amounts retroactive to the day immediately
following the Date of Termination. The amounts payable under Section&nbsp;2 of this&nbsp;<U>Schedule A</U>&nbsp;shall be paid in a lump sum on the first payroll date following the effective date of the Separation Agreement and Release and, in any
case, within 60 days after the Date of Termination; provided, however, that if <FONT STYLE="white-space:nowrap">the&nbsp;60-day&nbsp;period</FONT> begins in one calendar year and ends in a second calendar year, such amounts to the extent they
qualify <FONT STYLE="white-space:nowrap">as&nbsp;&#147;non-qualified&nbsp;deferred</FONT> compensation&#148; within the meaning of Section&nbsp;409A of the Code, shall be paid no earlier than the first Company payroll date in the second calendar
year and, in any case, by the last day of <FONT STYLE="white-space:nowrap">such&nbsp;60-day&nbsp;period.</FONT> Notwithstanding the foregoing, payments of the Severance Amount shall cease or shall not be paid if the Eligible Participant breaches any
of the Eligible Participant&#146;s continuing obligations under the Separation Agreement and Release. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Change in Control Severance Benefits </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
the event of a termination of an Eligible Participant&#146;s employment under the circumstances set forth in Section&nbsp;5 of the Plan, and subject to the terms and conditions of the Plan, the Eligible Participant shall be entitled to the following
severance payments and benefits: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An amount equal to (i)&nbsp;in the case of the NEO Participants, 1.5 times the sum of the NEO
Participant&#146;s Base Salary and Target Bonus and (ii)&nbsp;in the case of the Executive Team Participants, 1.0 times the Executive Team Participant&#146;s Base Salary and Target Bonus; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An amount equal to <FONT STYLE="white-space:nowrap">a&nbsp;pro-rata&nbsp;portion</FONT> of the Eligible
Participant&#146;s Target Bonus, with <FONT STYLE="white-space:nowrap">such&nbsp;pro-ration&nbsp;determined</FONT> based on the number of full months elapsed in the calendar year through the Date of Termination relative to the total number of full
months in the calendar year of termination; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Eligible Participant is enrolled in the Company&#146;s health care programs immediately prior to the
Date of Termination and properly elects to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;COBRA&#148;), COBRA premiums for the Eligible Participant and the Eligible Participant&#146;s eligible
dependents for (i) 18 months in the case of the NEO Participants and (ii) 12 months in the case of the Executive Team Participants (such amounts, the &#147;CIC COBRA Payments&#148;); provided, however, if the Company determines that it cannot pay
the CIC COBRA Payments without potentially violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service Act), the Company will in lieu thereof provide to the Eligible Employee a taxable monthly payment in
an amount equal to the COBRA premiums for the Eligible Participant and the Eligible Participant&#146;s eligible dependents for (i) 18 months in the case of the NEO Participants and (ii) 12 months in the case of the Executive Team Participants. For
the avoidance of doubt, the taxable payments described above may be used for any purpose, including, but not limited to, continuation coverage under COBRA; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Except as otherwise expressly provided in any applicable Equity Award agreement, in the event that Equity
Awards are assumed, continued or substituted in the Change in Control, effective as of the Accelerated Vesting Date: (A) 100% of all Stock Options and Time-Based Awards held by the Eligible Participant shall accelerate and become fully exercisable
or nonforfeitable; and (B)&nbsp;all Performance-Based Awards held by the Eligible Participant shall become exercisable or nonforfeitable (with performance deemed to be met at the greater of the target level of performance or the actual level of
performance on the date of termination). provided, however, in the event that Equity Awards are not assumed, continued or substituted in the Change in Control, (A) 100% of all Stock Options and Time-Based Awards held by the Eligible Participant
shall immediately accelerate and become fully exercisable or nonforfeitable as of the date of the Change in Control; and (B)&nbsp;all Performance-Based Awards held by the Eligible Participant shall become exercisable or nonforfeitable (with
performance deemed to be met at the greater of the target level of performance or the actual level of performance on the date of termination) as of the date of the Change in Control. Notwithstanding anything to the contrary in the applicable plans
and/or award agreements governing the Equity Awards, any termination or forfeiture of unvested shares underlying the Equity Awards that could vest </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
pursuant to this Section&nbsp;4 of&nbsp;<U>Schedule B</U>&nbsp;and otherwise would have occurred on or prior to the Accelerated Vesting Date will be delayed until the Accelerated Vesting Date and
will occur only to the extent the Equity Awards do not vest pursuant to this Section&nbsp;4 of&nbsp;<U>Schedule B</U>. Notwithstanding the foregoing, no additional vesting of the Equity Awards shall occur during the period between the Eligible
Participant&#146;s Date of Termination and the Accelerated Vesting Date. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The amounts payable under Sections 1, 2 and 3 of
this&nbsp;<U>Schedule B</U>&nbsp;shall be paid on the first payroll date following the effective date of the Separation Agreement and Release and, in any case, within 60 days after the Date of Termination; provided, however, that if <FONT
STYLE="white-space:nowrap">the&nbsp;60-day&nbsp;period</FONT> begins in one calendar year and ends in a second calendar year, such payments to the extent they qualify <FONT STYLE="white-space:nowrap">as&nbsp;&#147;non-qualified&nbsp;deferred</FONT>
compensation&#148; within the meaning of Section&nbsp;409A of the Code, shall be paid no earlier than the first Company payroll date in the second calendar year and, in any case, by the last day of
<FONT STYLE="white-space:nowrap">such&nbsp;60-day&nbsp;period.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>d554431dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD ROWSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt;margin-bottom:1pt">


<IMG SRC="g554431page1a.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD ROWSPAN="3" VALIGN="top"></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="top" ROWSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repligen Corporation</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">41 Seyon
Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Building #1, Suite 100</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Waltham, Massachusetts
02453</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt"></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REPLIGEN APPOINTS JASON K. GARLAND AS CHIEF FINANCIAL OFFICER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WALTHAM, Mass., September</B><B></B><B>&nbsp;12, 2023 &#151; </B>Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing
technology leadership, today announced that it has appointed Jason K. Garland as Chief Financial Officer (&#147;CFO&#148;), effective September&nbsp;25, 2023. Mr.&nbsp;Garland is joining Repligen from his most recent role with medical device
outsource (MDO) manufacturer Integer Holdings Corporation (&#147;Integer&#148;), where he served for nearly five years (2018-2023) as Executive Vice President and CFO. He succeeds retiring CFO Jon K. Snodgres, who joined the Company in June 2014 and
will continue in a full-time advisory role until October&nbsp;6, working closely with Mr.&nbsp;Garland to ensure a smooth transition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In this strategic
CFO role, Mr.&nbsp;Garland will act as a key partner to the business, with responsibility for all corporate finance and audit functions, capital markets and M&amp;A transactions, financial planning and analysis, budgeting and risk management. He
brings to the Company more than 25 years of relevant experience at large, multi-site organizations experiencing strong growth. This includes a division-level role within General Electric Company (&#147;GE&#148;) where he served as the CFO of a
$4&nbsp;billion dollar business with over 40 global manufacturing sites. In his most recent public company CFO role at Integer, he helped scale the enterprise to $1.4&nbsp;billion in revenue (2022), and he and his team supported Integer in
evaluating and integrating four acquisitions. At Integer, Mr.&nbsp;Garland also assumed executive sponsorship of the company&#146;s Business Process Excellence initiative focused on standardizing and optimizing all
<FONT STYLE="white-space:nowrap">non-manufacturing</FONT> processes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tony J. Hunt, President and Chief Executive Officer at Repligen, said,
&#147;Jason&#146;s financial acumen and rich experience&nbsp;as a business-driven, operational CFO at both large global and growth-focused organizations will serve Repligen well, as we continue to focus on driving success for our company through
innovation, including M&amp;A, while delivering above-industry growth and strong financial performance.&#148; He continued, &#147;We thank Jon for his dedicated service to the Company over the past nine years. He has truly been a great partner and
instrumental in bringing Repligen to where it is today, and we wish him well in his retirement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to his role with Integer, Mr.&nbsp;Garland
spent three years as Vice President and CFO for the global sales and supply divisions of Tiffany&nbsp;&amp; Co., a role he moved into following nearly 20 years in various roles of increasing responsibility at GE. His rotations and achievements at GE
culminated in several leadership positions including his last, aforementioned role as CFO for GE Industrial Solutions; at the time a $4&nbsp;billion product, service and software revenue business operating globally with approximately 18,000
employees. Currently, Mr.&nbsp;Garland serves on the Board and is Audit Chair for Acutus Medical, a publicly traded medical device company. He holds a Bachelor of Science in Chemical Engineering from the University of New Hampshire, and has Lean Six
Sigma Black Belt certification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Garland said, &#147;I am thrilled to be joining Repligen, and look forward to applying my
experience to support the Company&#146;s financial and operational performance. I look forward to meeting my new colleagues and working to execute on transactions and strategies that can build on Repligen&#146;s innovation edge in the bioprocessing
market.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Snodgres said, &#147;I welcome Jason to the Company and look forward to working together through a transition period, introducing
him to internal and external stakeholders and getting familiar with Repligen processes and systems. I&#146;m proud of what we have accomplished over the last nine years and am truly grateful for having been part of an exceptional team at
Repligen.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Repligen Corporation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Repligen
Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are <I>&#147;inspiring advances in
bioprocessing&#148;</I> for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process
Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For
more information about the our company see our website at www.repligen.com,and follow us on LinkedIn. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release may contain forward-looking
statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like
&#147;believe,&#148; &#147;expect,&#148; &#147;may,&#148; &#147;will,&#148; &#147;should,&#148; &#147;seek,&#148; or &#147;could&#148; and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any
responsibility to update any forward-looking statements, except as required by law. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Repligen Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sondra S. Newman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Global Head of Investor Relations </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(781) <FONT STYLE="white-space:nowrap">419-1881</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investors@repligen.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"># # # </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rgen-20230908.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 4:25:39 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:rgen="http://www.repligencorp.com/20230908"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.repligencorp.com/20230908"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rgen-20230908_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rgen-20230908_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>rgen-20230908_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 4:25:39 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>rgen-20230908_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 9/12/2023 4:25:39 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rgen-20230908.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g554431page1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g554431page1a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MS].*N>#J2FY)K4B&+A&*33T,>T;7/B#X_P!(UU-(:SL+9HV$K;C'LC?<WSD
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M:)_UXP?^BUKFK?Q)>K.BE_#CZ(\Y\>_\EA\,?]NW_H]J[L/_ +O/Y_D<=?\
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M/#G_ $ -,_\  2/_  K@]M4_F?WG;[*G_*ON-2**.WA2&&-8XHU"HB#"J!P
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MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
1"@ H * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140315968038192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">REPLIGEN CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000730272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  08,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-14656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2729386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">41 Seyon Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Bldg. 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Waltham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">250-0111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RGEN<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d554431d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rgen-20230908.xsd" xlink:type="simple"/>
    <context id="duration_2023-09-08_to_2023-09-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000730272</identifier>
        </entity>
        <period>
            <startDate>2023-09-08</startDate>
            <endDate>2023-09-08</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-09-08_to_2023-09-08"
      id="Hidden_dei_EntityRegistrantName">REPLIGEN CORP</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-09-08_to_2023-09-08">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-09-08_to_2023-09-08"
      id="Hidden_dei_EntityCentralIndexKey">0000730272</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-09-08_to_2023-09-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-09-08_to_2023-09-08">2023-09-08</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-09-08_to_2023-09-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-09-08_to_2023-09-08">000-14656</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-09-08_to_2023-09-08">04-2729386</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-09-08_to_2023-09-08">41 Seyon Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-09-08_to_2023-09-08">Bldg. 1</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2023-09-08_to_2023-09-08">Suite 100</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-09-08_to_2023-09-08">Waltham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-09-08_to_2023-09-08">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-09-08_to_2023-09-08">02453</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-09-08_to_2023-09-08">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-09-08_to_2023-09-08">250-0111</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-09-08_to_2023-09-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-09-08_to_2023-09-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-09-08_to_2023-09-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-09-08_to_2023-09-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-09-08_to_2023-09-08">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-09-08_to_2023-09-08">RGEN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-09-08_to_2023-09-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-09-08_to_2023-09-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M[3W/X 1VW:=1<(&?^P/Z"X92+0L4M^\'Z4-4%J%,,.=M$/&Z[J5+*3HCJZ6
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M/UY_ 5!+ 0(4 Q0    ( )!*+%<'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ D$HL5]0HP(OM
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ D$HL5YE<G",0!@  G"<  !,              ( !RP$  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "02BQ7#B5X'FP$  #%$0  &
M            @($,"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ D$HL5Y^@&_"Q @  X@P   T              ( !K@P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "02BQ7EXJ[',     3 @  "P
M    @ &*#P  7W)E;',O+G)E;'-02P$"% ,4    " "02BQ7'#AEZC\!   \
M @  #P              @ %S$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ D$HL5R0>FZ*M    ^ $  !H              ( !WQ$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ D$HL5V60>9(9 0  SP,
M !,              ( !Q!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d554431d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d554431d8k.htm">d554431d8k.htm</File>
    <File>d554431dex101.htm</File>
    <File>d554431dex991.htm</File>
    <File>rgen-20230908.xsd</File>
    <File>rgen-20230908_lab.xml</File>
    <File>rgen-20230908_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d554431d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d554431d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rgen-20230908_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rgen-20230908_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rgen-20230908.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rgen",
   "nsuri": "http://www.repligencorp.com/20230908",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d554431d8k.htm",
      "contextRef": "duration_2023-09-08_to_2023-09-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d554431d8k.htm",
      "contextRef": "duration_2023-09-08_to_2023-09-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.repligencorp.com//20230908/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-23-233111-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-233111-xbrl.zip
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M7%R\4'P2>2'UF8B4-R,*%%X-9WJ$^ $Q 'X9.!*O)V3*B1'T(PGU9\F]H?"
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MP,*D,2 PC4C!2,E ^)%6IBA '=]OO\&+Y1PN#%<CF$N5S1 "@!*;S6LU^!>
M<=".$M"OP).C/J;S^!FBIYEZ0&<Z5*/.@!'"#QG.R$[3VC4DN( _"!V&R>I
MSI)J2TC5<P+G-4+H"](':D60> A H0 PD3582$AM=-'@'%.(4%B(B 4$K4/
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MAF^66?*OM('/_I+6!?[D?^?T@YIV;7ZAW!'CQYI%6A0PK&FU5(F:S=04/Y7
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MET[L$J\=E+O^X#CCK4V.(YH5<]CWXR*=OM][-UU4!8C54K6+*JN*:GYE+OI
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M AA 3*W U,@9A!N]R%<;R)PFPP,T[J<,$G.7[@Y*8/ <5#E\=IGF)<:;"AQ
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MPW_L>NVZL-VB?J@P7E.^@#Q4D!%D4DO<]K\:_:O+U,BM1_3Y;)87N>%;D#B
M?S&L/0VA .T<R4BCPI/)L7:Z .@N4N@-[AS<E6^;XR$D1)1NYK#(I\5P&7&[
M<QP=)<:2.$J57>1-I.H[FJG@.TQ'">26YQ=/JP[\V\(D($#$I451>%:_U:3$
M@^])B2_/R?J<(P7)"5ID@NR^?5/_:#?HK>EI#:<*@A4_UD(PF8L^VW2<+*(+
M0V 2;D0DO3"W?,XY/KKV' ]VD]]78)VJ=&D"HN13-I9 H:TJS EGH+OED],%
M7#QIBS'1U>+*0O"<CX#:;;65J?\,FND'M.E)A2S1Y6O<*PEU=8FY#K1HRHR^
MD!978.LW6GG/JFE'$)B-[@2N$>R"=B7LD\@+*[H\2QRXOS.BW2<RSJ]@=PYW
MB9;<9,$-E(U0E]C02:"6IL8WK_0N#G_<2R=3=44M2"J;T0 3K390!@D/H)=#
M!3-8=$&XO8$G.7P"+E$;D4,S9PNVQ-+8'^^^^1I<_./=J&<=4A*XISZ,8E!3
M]5F*0LL](X,D@6T6@;6'#=49,Y5$]+X/>E8.]"26>JE!EA8$HES /?T5$'$_
MWW6(;-=Y*O'U1GRD,>)#M\\PO02>7<!5NBYFDNQ@1G0F<>PEVV:8\;M4!;QA
MY^#0Y: .25>1F7*+".JNP2%*1;/3*&@!UA;W<\'^-;"JF==NF4G8-H3('7K8
MC=H2C/$]9&LSU6"\# B%4<:R+]",S=)M2"6^AF-,Q-2?&JL[O/_)L;K@M#Z&
M*V_7";V!UU6C[4.^7#P$)R,EGPJ;IV-[/DZJ\!\H=U-W7"/@NFF)1*+IFSEJ
M!_E$7L(5"&Z&0Z75< BE('H<-R!22^ MOE [-B'NS9I6QGT,(>BXA*0UR$]=
M--6F[VU[UX_/#.^*]Y,/K[!=$9X9OBR=ZW6P</?:0[M;%@YO>3G#B>$,K(/&
MX(57J.H5/(5C7:>%#PZ_)!_&&2)R]K 2_<IM0D?]Z@P:(72*)8M-L!0DX60C
MH0^:P.@'.(7&M?0;G/B<=)R.5W G=88>M'9@?S1"]NQU"-4D:"_##@Q://PJ
M*8'E!+6J<;FR4I[[AGRP%@B4M&@(/\FWIB3.P,<CW"H?I9_HDG,Z40UVQ:DK
MS)YDNAHKM$5,KLY%(;EQT$@<A]+\ C^60HOU^TB9R^CP#(I]#<3##-% D\B-
M>F_*)1B$Z15U\FPTUM25/LO3)Q%9%[C5F\AXY,]D$B%?,^,[KYTZ+5O#,0LV
MSR0VS:--(8=:GH-6D?YKL\U7=UF5>QP7,_"/H7)\?!FANS6P;FC2HO@E^Z(W
M\.;U%7/"O 1U/;?IR;=JWA7(JWW5)ULXT>R0F=OT>OA@1;,XZ*!J9C]&X/2.
MG]Q4F9H17":";<8M+M)\V;!KQ <)]HRS$CEXQ!(&]JJ7S@E>8]LP=H2U3^<I
MMN6C_2L=/+EWB$5-ZMHNRANP?$V9K&-J8OM8 ;(BR#E7DP7G^S)MABHS!JA>
M"4<TM9LQ3''86Q*VZCW29HF@NYS-[&ZF%VE>:!K/I5)!$)(2(!A49Q] 5R,R
M*K76_<91:3$D/"6</Q>_#2TK+->R:[EY,\P(%C6GBCH4U4\7-\+UA622PR(7
M+BG_FAKYS<W=AB<9CI#(X$RA)X64H:U8+TBB7^ 59DY1VH'?7^<:@G)E89>Q
M![.(-1\A8\DU1,S/=1FB^(BKEVY#/,L?&(_6?,1Z\)*)Z-J]:K:WJJ;OE31B
M48;PWJT6L>3TVV*.@DO;O6I[N2<L.^$'KO6IOI0&7DC=])]"CQLS#=WT2-X*
MTIFB&UC4@[D".JXI WLQ*)0N4\RM4!ZQUPE)%"+E&YSB2+"R+5%V#^YE:TSY
MQMT H/E17^*I,?:XIPHX>\H.T$R%(, Z:8G@,)79RAPZ+CRP_>1H*K71B)QP
M<  ^\YH#6S^JSW,=*859G.0-UC6[B.!(J6%/D;A;$/(G\M 4UQ2+,=A85HN)
M%+K4ZXQ3_SPZI/"3(-/I5 71,N6.9&C#<2+IR=R(E;6#'/S/>$1]"X5-M\ >
MRY3[Q')1V31GZ0T"H5EP*(8G>Z%=.VE=R5L;923X%M-3#[^GI[Y$8X0W!I1P
M8OS(J%O<@_*5PH6,]=:IY2'TD\)DV@S5.0H-*J5:#=VCO? ';O1DCK8.,5J@
MH3.'N_B*Z[Z7H!$;O]3/Q8H8!+ ]@QY]E3Y6)7-,A@?GK&_0A&LR'NE%Z:$*
MMET)PIDQE9=FZW.]'*J5J\M>I,],J3'\)A;=8EB!-#S<^Z9;!K/->X76*$8
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M[DB(*PVBUG$C3S_*+HF)TPH,W@M"!\_;%$J4)_;@_FGK?FJG3ZX_'KEDAVZ
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M KFSKQ$G-CJ=C-KT"6W36@V\KIGU3E4G'JIV%U1IUFP$C&__2J]:6^K@D"C
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M0F2I7X+.:IK[Q0"+UI5(ZTC%)B(96ZZ2USPLJFC&VS&D0YG52 3OP2BV>T-
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M?RLA11N74]<RSCH'3_N9,+K7RS('SS$Y[C+LLOU688,Q@M81BR4[%@<_/7K
M!)+,R)+L\'%X_OKX[9$!F])/5A]HD/1:MN.UK!FFB#Q3*T4.B7VJ/8EOI&M
MKX IHB1-$G"(\2]O83-*R@.D5Z[Z;$QL:E41]H+<[XN\0A@CQBP]QDBG6W<\
M<.P7^_QX\-" 9=]TY_"@Y%>6C'="LP$;L>NG88G/2<>[6\G2:(SO.G1<:HKN
MC0K7)'#ET(7PF;<VB>RL=+6(;"U7#E 2$?6*3@=E57<N-0)Z0C:E;:AGTG.X
M>30A4-<(^HV20ER*X,7X^TTP)SJMS0<BN,=H76P'Q/7<M=^O@$^Y NY]A5<
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M-8-]5!B3K!40#Z&X,!P:NPD7&%PF@;(6_3-AHVU,Y5+!W,V:4RF $ZCV=VD
M5'T)#RBU;Q61GW+>]#C>MP>DF49SQ!P^KSSFY;/':987*J%^R(.1T.=E3"PX
M)=RF5/"@.I01<:U!84(U9%4?F=7ZR"?'))1'U*:H46E\W26Y9.22B4HE;N<
M-QJ)++@E-T&RJ-<J4?\ U#M/-,#K#&VYJ-M7YD(/?$NX),&/3_DM0KVV?+&F
M;!:JHX<G?QQ9,;7;-O/&QR>)<A3UN#I'?3&>F-D\ON[68DK,!X1ZU1W\R2J5
M0Y0ABAH;'@*HO K-< :AN-I=XWPZCG.T*\=P+)3@5&SL]PY\Z* VSORX2\9W
MDO6A/G=%, _\_NO>P;Q,1.\!XY*/3\-T /G%H28!H<Y8K8D$IT4*E5%U>V6;
M*C*H/7 T#0KK256/KNJPVB*]/#J^Z.>O*'Y-C,0"SNR7+G1#DDI'UN]$FR(
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M_HCM8C?+:$;%%$YYM*M<6UU8Y7XM,]?V06X24%/L>Y^47&0S'-]3*DY\@NA
MB.H2?-&V!?D_;(5<!GNIN<,#YAGF]1GS9I[(Q2-_ U!+ 0(4 Q0    ( )!*
M+%=3:[N@:1,  *9R   .              "  0    !D-34T-#,Q9#AK+FAT
M;5!+ 0(4 Q0    ( )!*+%=F,VX;@U\  (?4 0 1              "  943
M  !D-34T-#,Q9&5X,3 Q+FAT;5!+ 0(4 Q0    ( )!*+%=]J?"."0X  (HH
M   1              "  4=S  !D-34T-#,Q9&5X.3DQ+FAT;5!+ 0(4 Q0
M   ( )!*+%?J[&"V0 ,  %@+   1              "  7^!  !R9V5N+3(P
M,C,P.3 X+GAS9%!+ 0(4 Q0    ( )!*+%=P+Y?MGP8  +A)   5
M      "  >Z$  !R9V5N+3(P,C,P.3 X7VQA8BYX;6Q02P$"% ,4    " "0
M2BQ7,3JOC]<$   *+@  %0              @ ' BP  <F=E;BTR,#(S,#DP
?.%]P<F4N>&UL4$L%!@     &  8 ?P$  ,J0      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
